Parthenon LLC decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 0.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 31,418 shares of the company’s stock after selling 300 shares during the quarter. Parthenon LLC’s holdings in Colgate-Palmolive were worth $1,870,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in the company. Farmers & Merchants Trust Co of Chambersburg PA grew its stake in Colgate-Palmolive by 46.2% in the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 950 shares of the company’s stock valued at $57,000 after buying an additional 300 shares during the last quarter. Moody National Bank Trust Division acquired a new position in Colgate-Palmolive in the 4th quarter valued at $94,000. Price Capital Management Inc. acquired a new position in Colgate-Palmolive in the 3rd quarter valued at $121,000. O Brien Wealth Partners LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at $123,000. Finally, IMS Capital Management grew its stake in Colgate-Palmolive by 631.6% in the 3rd quarter. IMS Capital Management now owns 2,085 shares of the company’s stock valued at $140,000 after buying an additional 1,800 shares during the last quarter. Institutional investors own 74.47% of the company’s stock.
NYSE CL opened at $65.05 on Friday. The firm has a market capitalization of $56.42 billion, a price-to-earnings ratio of 21.90, a P/E/G ratio of 4.20 and a beta of 0.78. Colgate-Palmolive has a 52-week low of $57.41 and a 52-week high of $73.14.
The business also recently declared a quarterly dividend, which will be paid on Friday, February 15th. Shareholders of record on Wednesday, January 23rd will be given a $0.42 dividend. The ex-dividend date of this dividend is Tuesday, January 22nd. This represents a $1.68 annualized dividend and a yield of 2.58%. Colgate-Palmolive’s dividend payout ratio is 56.57%.
A number of research analysts recently issued reports on CL shares. Wells Fargo & Co lowered their target price on shares of Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating on the stock in a research note on Wednesday, October 17th. UBS Group set a $71.00 target price on shares of Colgate-Palmolive and gave the company a “buy” rating in a research note on Wednesday, October 17th. SunTrust Banks lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their target price for the company from $80.00 to $65.00 in a research note on Friday, October 26th. JPMorgan Chase & Co. lowered shares of Colgate-Palmolive from a “neutral” rating to an “underweight” rating and lowered their target price for the company from $61.00 to $54.00 in a research note on Monday, October 29th. Finally, Citigroup lowered their target price on shares of Colgate-Palmolive from $68.00 to $63.00 and set a “hold” rating on the stock in a research note on Monday, October 29th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $65.00.
In other Colgate-Palmolive news, Director John T. Cahill sold 5,780 shares of the firm’s stock in a transaction on Thursday, January 31st. The shares were sold at an average price of $64.46, for a total value of $372,578.80. Following the sale, the director now directly owns 27,820 shares in the company, valued at approximately $1,793,277.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Read More: Bid-Ask Spread
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.